Ultrasensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) detection in early stage non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Isbell, J. M.; Goldstein, J. S.; Hamilton, E. G.; Liu, S. Y.; Eichholz, J.; Buonocore, D. J.; Rusch, V. W.; Bott, M.; Molena, D.; Rocco, G.; Yang, S. R.; Rudin, C. M.; Jones, D. R.; Roff, A.; Schultz, A.; Chabon, J. J.; Kurtz, D. M.; Alizadeh, A. A.; Li, B. T.; Diehn, M. |
| Abstract Title: | Ultrasensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) detection in early stage non-small cell lung cancer (NSCLC) |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401867 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.8078 |
| Notes: | Meeting Abstract: 8078 -- Source: Wos |
